DK1125130T3 - Påvisning af syreresistente mikroorganismer i afföringen - Google Patents

Påvisning af syreresistente mikroorganismer i afföringen

Info

Publication number
DK1125130T3
DK1125130T3 DK99971515T DK99971515T DK1125130T3 DK 1125130 T3 DK1125130 T3 DK 1125130T3 DK 99971515 T DK99971515 T DK 99971515T DK 99971515 T DK99971515 T DK 99971515T DK 1125130 T3 DK1125130 T3 DK 1125130T3
Authority
DK
Denmark
Prior art keywords
epitopes
mab
fragments
bind
derivatives
Prior art date
Application number
DK99971515T
Other languages
Danish (da)
English (en)
Inventor
Christian Reiter
Gerhard Cullmann
Ulrike Friedrichs
Petra Heppner
Meret Lakner
Achim Ringeis
Original Assignee
Dakocytomation Denmark As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26149749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1125130(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dakocytomation Denmark As filed Critical Dakocytomation Denmark As
Application granted granted Critical
Publication of DK1125130T3 publication Critical patent/DK1125130T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK99971515T 1998-10-29 1999-10-29 Påvisning af syreresistente mikroorganismer i afföringen DK1125130T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98120517 1998-10-29
EP98120687 1998-11-06

Publications (1)

Publication Number Publication Date
DK1125130T3 true DK1125130T3 (da) 2006-11-27

Family

ID=26149749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99971515T DK1125130T3 (da) 1998-10-29 1999-10-29 Påvisning af syreresistente mikroorganismer i afföringen

Country Status (9)

Country Link
US (2) US7122320B2 (enExample)
EP (2) EP1734366A3 (enExample)
JP (1) JP2002529705A (enExample)
AT (1) ATE334395T1 (enExample)
AU (1) AU1157100A (enExample)
DE (1) DE59913716D1 (enExample)
DK (1) DK1125130T3 (enExample)
ES (1) ES2270638T3 (enExample)
WO (1) WO2000026671A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1734366A3 (de) * 1998-10-29 2007-11-07 Oxoid (Ely) Limited Neues Verfahren zum Nachweis von Säure-resistenten Mikroorganismen im Stuhl
EP1232392B2 (de) * 1999-10-12 2014-04-02 Oxoid (Ely) Limited Verbessertes verfahren zum nachweis von säure-resistenten bakterien der gattung helicobacter im stuhl
JP3504633B2 (ja) 1999-10-29 2004-03-08 わかもと製薬株式会社 ヘリコバクター・ピロリへの感染を判定する検査方法及び検査試薬
EP1227159B1 (en) 1999-10-29 2011-04-20 Wakamoto Pharmaceutical Co., Ltd. Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
DE60138981D1 (de) * 2000-05-18 2009-07-30 Meridian Bioscience Inc Immunoassay für H. pylori in Fäkalienproben mit Hilfe von gattungsspezifischen Antikörpern
DE10043161A1 (de) * 2000-09-01 2002-03-14 Connex Ges Zur Optimierung Von Lösung zur Aufbereitung von Stuhlproben für diagnostische Zwecke
BR0207068A (pt) * 2001-01-26 2004-12-21 Inhibitex Inc Anticorpo monoclonal para a protéina clfa, anti-soro isolado, anticorpo isolado e anticorpo humanizado contendo o referido anticorpo, kit diagnóstico compreendendo o referido anticorpo, método para diagnóstico de uma infecção por s.aureus, composição farmacêutica para o tratamento ou prevenção da referida infecção, método para indução de de uma resposta imunológica, método para identificação de anticorpos monoclonais para a protéina clfa e fragmento ativo isolado a partir do domìnio a da protéina clfa do s.aureus
FI118061B (fi) 2001-09-24 2007-06-15 Beanor Oy Menetelmä ja bioanturi analyysiä varten
FI115166B (fi) 2001-12-31 2005-03-15 Biofons Oy Diagnostisia menetelmiä
US20040023415A1 (en) * 2002-03-05 2004-02-05 Konstantin Sokolov Biospecific contrast agents
DE10219741A1 (de) * 2002-05-02 2003-11-13 Georg S Wengler Verfahren zur Vorbehandlung von Stuhlproben
GB0210783D0 (en) * 2002-05-10 2002-06-19 Polonelli Luciano Anti-microbial polypeptides
US20090191213A9 (en) 2003-07-02 2009-07-30 Novo Nordisk A/S Compositions and methods for regulating NK cell activity
KR20060079180A (ko) * 2003-07-02 2006-07-05 노보 노르디스크 에이/에스 Ｎｋ 세포 활성을 조절하기 위한 조성물 및 방법
DK2287195T3 (da) * 2004-07-01 2019-08-19 Innate Pharma Pan-kir2dl nk-receptor-antistoffer og anvendelse heraf i diagnostik og terapi
DE602005026538D1 (de) * 2004-07-01 2011-04-07 Innate Pharma An die rezeptoren kir2dl1, -2, -3, jedoch nicht kir2ds4, bindende antikörper und deren therapeutische verwendung
JP4625318B2 (ja) * 2004-12-06 2011-02-02 財団法人野田産業科学研究所 相同組換え頻度が上昇した形質転換菌
PL1836225T3 (pl) 2005-01-06 2012-05-31 Novo Nordisk As Czynniki wiążące kir i sposoby ich stosowania
WO2009088460A2 (en) * 2008-01-03 2009-07-16 Ask Diagnostics, Inc. Methods of diagnosing latent and active malignancies
US20110065086A1 (en) * 2008-02-21 2011-03-17 Otc Biotechnologies, Llc Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays
CA2871081A1 (en) * 2011-04-21 2012-10-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Peptide and conjugate vaccines for fungal infections
WO2016176176A1 (en) * 2015-04-29 2016-11-03 3M Innovative Properties Company Culture device for anaerobic microorganisms
CN109628457B (zh) * 2019-02-03 2021-12-10 淮海工学院 单链dna核酸适配体及其筛选方法与用途
CN110618270B (zh) * 2019-09-10 2020-08-25 深圳市鸿美诊断技术有限公司 一种用于定量测定粪便中幽门螺杆菌抗原试剂的制备方法
EP4204003A4 (en) * 2020-08-28 2024-08-21 Board of Regents, The University of Texas System ANTIBODIES SPECIFIC TO CCL21 AND METHODS OF USE
TW202317188A (zh) * 2021-06-22 2023-05-01 美商通用醫院公司 於癌症中治療靶向鈣黏蛋白11

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
JPS63273497A (ja) * 1986-12-26 1988-11-10 Meiji Seika Kaisha Ltd 抗カンピロバクターモノクローナル抗体
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1996034624A1 (en) * 1995-05-02 1996-11-07 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
GB2307987A (en) * 1995-12-06 1997-06-11 Univ Manchester Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto
US5716791A (en) * 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US6383763B1 (en) * 1996-07-26 2002-05-07 Case Western Reserve University Detection of mycobacteria
IT1289578B1 (it) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa Immunopurificazione di un antigene dall'apparente peso molecolare di 16 +- 2 kda dell' helicobacter pylori e metodi per la sua
EP1734366A3 (de) * 1998-10-29 2007-11-07 Oxoid (Ely) Limited Neues Verfahren zum Nachweis von Säure-resistenten Mikroorganismen im Stuhl

Also Published As

Publication number Publication date
US7736859B2 (en) 2010-06-15
JP2002529705A (ja) 2002-09-10
AU1157100A (en) 2000-05-22
US7122320B2 (en) 2006-10-17
EP1125130B1 (de) 2006-07-26
DE59913716D1 (de) 2006-09-07
WO2000026671A1 (de) 2000-05-11
US20040023316A1 (en) 2004-02-05
EP1734366A2 (de) 2006-12-20
EP1734366A3 (de) 2007-11-07
US20070009975A1 (en) 2007-01-11
ES2270638T3 (es) 2007-04-01
ATE334395T1 (de) 2006-08-15
EP1125130A1 (de) 2001-08-22

Similar Documents

Publication Publication Date Title
DK1125130T3 (da) Påvisning af syreresistente mikroorganismer i afföringen
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
Green et al. Specificity of the antibodies produced by single cells following immunization with antigens bearing two types of antigenic determinants
RU2004136285A (ru) Способ диагностики гепатоцеллюлярной карциномы
WO2001009190A3 (en) Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
ES2192611T3 (es) Procedimiento de eliminacion de la interferencia del factor reumatoide en los dosificados de diagnostico.
DE69531311D1 (de) Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben
RU2018103933A (ru) Моноклональные антитела, с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом
KR102078879B1 (ko) 돼지파보바이러스에 특이적인 단일클론항체 및 이의 용도
CA2589054A1 (en) Detection of a therapeutic antibody in an experimental animal
Butler et al. Heterogeneity of bovine IgG2. VI. Comparative specificity of monoclonal and polyclonal capture antibodies for IgG2a (A1) and IgG2a (A2)
CN117777286B (zh) 靶向降钙素原的抗体a4d7及其应用
KR102601835B1 (ko) 말 인플루엔자 바이러스 h3n8형에 특이적인 단일클론항체 및 이를 이용한 말인플루엔자 바이러스 검출용 조성물
KR102813284B1 (ko) 엔로플록사신에 특이적으로 결합하는 단일클론항체 및 이를 이용한 엔로플록사신 검출용 키트
KR20210116115A (ko) 돼지 유행성 설사병 바이러스와 결합하는 항체 및 이의 용도
KR102569269B1 (ko) 피검 대상의 검출 방법 및 그것을 위한 면역 측정 기구 및 모노클로널 항체
KR101851332B1 (ko) 스타필로코커스 아우레우스에 특이적인 신규한 단클론 항체, 이를 생산하는 하이브리도마, 이를 포함하는 검출용 조성물, 검출 방법 및 검출 키트
JP7372196B2 (ja) マイコプラズマ・ニューモニエの免疫測定方法及び免疫測定器具
KR20160072516A (ko) 스타필로코커스 아우레우스에 특이적인 신규한 단클론 항체, 이를 생산하는 하이브리도마, 이를 포함하는 검출용 조성물, 검출 방법 및 검출 키트
JP5711877B2 (ja) 癌の悪性度の検知方法及び癌の悪性度の診断剤
Zhou et al. Development of an immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay for detection of equine and swine IgM antibodies to vesicular stomatitis virus
KR20240034962A (ko) 구제역 바이러스 Asia 1형과 특이적으로 결합하는 항체 및 이의 용도
KR20230149702A (ko) 플루닉신에 특이적으로 결합하는 단일클론항체 및 이의 용도
KR950026888A (ko) 사카로마이세스-특이적 항원 및 항체, 이의 제조방법 및 용도
Wang et al. Generation and utilization of anti-drug monoclonal antibodies for screening of 36 drug users by dot-ELISA